As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

 

India diclofenac sodium market is expected to grow at a steady rate during the forecast period. Increasing aging population in the country is the key factor which is estimated to drive the India Diclofenac Sodium market over the forecasted years. In addition to this, high growth in the number of surgeries taking place is further expected to rev up the market growth through FY2026. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.

 

The India diclofenac sodium market is segmented based on product type, form, application, route of administration, source, distribution channel, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until FY2020 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of upsurge in the number of contract manufacturers in the country and increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration. This is further projected to contribute to the segmental growth in the coming years.

 

The major players operating in the India diclofenac sodium market are Novartis India Ltd, Hetero Drugs Ltd., Auro Laboratories Ltd., Aarti Drugs Ltd., J B Chemicals and Pharmaceuticals Ltd., Novartis India Ltd., Emkay Pharma Pvt. Ltd., Bestochem Formulations (India) Limited, Salvavidas Pharmaceutical Pvt. Ltd., Wellona Pharma Pvt. Ltd and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India diclofenac sodium market from FY2016 to FY2019.
  • To estimate and forecast the market size of India diclofenac sodium market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India diclofenac sodium market based on product type, form, application, route of administration, source, distribution channel, end user, company and regional distribution.
  • To identify dominant region or segment in the India diclofenac sodium market.
  • To identify drivers and challenges for India diclofenac sodium market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India diclofenac sodium market.
  • To identify and analyze the profile of leading players operating in India diclofenac sodium market.
  • To identify key sustainable strategies adopted by market players in India diclofenac sodium market.

Click here to download the sample


TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India diclofenac sodium market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Diclofenac sodium manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to diclofenac sodium

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India diclofenac sodium market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Diclofenac Sodium Market, By Product Type:
    • Prescription
    • OTC
  • India Diclofenac Sodium Market, By Form:
    • Tablet
    • Injection
    • Gel
    • Others
  • India Diclofenac Sodium Market, By Application:
    • Osteoarthritis
    • Ankylosing Spondylitis
    • Dysmenorrhea
    • Rheumatoid arthritis
    • Migraine
    • Pain
    • Others
  • India Diclofenac Sodium Market, By Route of Administration:
    • Oral
    • Intravenous
    • Topical
    • Others
  • India Diclofenac Sodium Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Diclofenac Sodium Market, By Distribution Channel:
    • Online
    • Offline
  • India Diclofenac Sodium Market, By End User:
    • Adult
    • Paediatric
  • India Diclofenac Sodium Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India diclofenac sodium market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India diclofenac sodium market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Diclofenac Sodium Market

4.    Executive Summary

5.    Manufacturing Diclofenac Sodium

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Diclofenac Sodium

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Diclofenac Sodium Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type (Prescription v/s OTC)

7.2.2.     By Form (Tablet, Injection, Gel, Others)

7.2.3.     By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others)

7.2.4.     By Route of Administration (Oral, Intravenous, Topical, Others)

7.2.5.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.6.     By Distribution Channel (Online v/s Offline)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Novartis India Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Hetero Drugs Ltd.

14.1.3.  Auro Laboratories Ltd.

14.1.4.  Aarti Drugs Ltd.

14.1.5.  J B Chemicals and Pharmaceuticals Ltd.

14.1.6.  Novartis India Ltd.

14.1.7.  Emkay Pharma Pvt. Ltd.

14.1.8.  Bestochem Formulations (India) Limited

14.1.9.  Salvavidas Pharmaceutical Pvt. Ltd.

14.1.10.                Wellona Pharma Pvt. Ltd.

15.  Strategic Recommendations

About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com